Sodium-Glucose Cotransporter-2 Inhibitor for Acute Cardiorenal Syndrome: A Feasibility Study

Conditions: Cardiorenal Syndrome Interventions: Drug: Dapagliflozin Sponsors: Yale University; American Heart Association Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials